Vijan Kalaivaani, Ali Athirah, Mohamed Idrus Nur Adhajirin, Lourdesamy Priscilla, Margammuthu Shamini, Perumal Suguna, Teng Cheong Lieng, Ahmad Imran
MBBS, icFRACGP, Klinik Kesihatan Kuala Pilah Jalan Macpherson, Kampung Tebat Kening, Kuala Pilah, Negeri Sembilan, Malaysia. Email:
MD, icFRACGP, Klinik Kesihatan Salak, Jalan Salak, Sepang, Selangor, Malaysia.
Malays Fam Physician. 2024 Aug 16;19:51. doi: 10.51866/oa.629. eCollection 2024.
Metabolic-associated fatty liver disease (MAFLD) is the liver manifestation of metabolic syndrome, which is commonly seen in primary care settings. This study aimed to determine the knowledge and practice of primary care physicians regarding MAFLD in Seremban District, Negeri Sembilan.
This cross-sectional study was conducted among medical officers in 14 health clinics in Seremban District, using a validated, self-administered online questionnaire.
A total of 240 medical officers from 14 health clinics in Seremban District, participated in this study. Most participants (85.4%) passed the knowledge test. Their practice was acceptable, but only a minority were familiar with non-invasive testing of liver fibrosis (e.g. APRI or FIB-4), medication and specific diet for the treatment of MAFLD.
Most primary care physicians in Seremban District are knowledgeable in identifying risk factors and managing patients with MAFLD. However, there are still areas to improve in terms of management, particularly regarding the use of silymarin, vitamin E and pioglitazone.
代谢相关脂肪性肝病（MAFLD）是代谢综合征的肝脏表现，在基层医疗环境中较为常见。本研究旨在确定马来西亚森美兰州芙蓉地区基层医疗医生对MAFLD的认知和实践情况。
本横断面研究在芙蓉地区14家健康诊所的医务人员中进行，使用经过验证的自填式在线问卷。
芙蓉地区14家健康诊所的240名医务人员参与了本研究。大多数参与者（85.4%）通过了知识测试。他们的实践情况尚可，但只有少数人熟悉肝纤维化的非侵入性检测（如APRI或FIB-4）、治疗MAFLD的药物和特定饮食。
芙蓉地区的大多数基层医疗医生在识别MAFLD的危险因素和管理患者方面知识丰富。然而，在管理方面仍有改进空间，特别是在水飞蓟素、维生素E和吡格列酮的使用方面。
